Skip to main content Accessibility help

Login Alert

Cancel
Log in
×
×
Register
Log In
(0) Cart
Logo for Cambridge Core from Cambridge University Press. Click to return to homepage.
Logo for Cambridge Core from Cambridge University Press. Click to return to homepage.
Cited by
  • Crossref logo 98
  • Google Scholar logo
Crossref Citations
Crossref logo
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Parks, Natalie E. 2020. Navigating the TOR of Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 47, Issue. 4, p. 435.
  • CrossRef
  • Google Scholar
Totolyan, N. A. Alifirova, V. M. Bakhtiyarova, K. Z. Boyko, A. N. Vlasov, Ya. V. Goncharova, Z. A. Zakharova, M. N. Kasatkin, D. S. Kotov, S. V. Nilov, A. I. Sivertseva, S. A. Sokolova, A. A. Spirin, N. N. Khabirov, F. A. and Paradnika, D. 2020. Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets. Neurology, Neuropsychiatry, Psychosomatics, Vol. 12, Issue. 5, p. 138.
  • CrossRef
  • Google Scholar
Lees, Samuel Dicker, Mathew Ku, Jie En Chaganti, Varun Mew-Sum, Matthew Wang, Nick Smith, Angela Oldmeadow, Christopher Goon, Wooi Lynn Bevan, Marc Lang, Danielle and Hinwood, Madeleine 2021. Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis. BMJ Open, Vol. 11, Issue. 11, p. e051509.
  • CrossRef
  • Google Scholar
Hartung, Hans-Peter Meuth, Sven G. Miller, Deborah M. and Comi, Giancarlo 2021. Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis. Current Opinion in Neurology, Vol. 34, Issue. 4, p. 598.
  • CrossRef
  • Google Scholar
Caparó-Zamalloa, César Velásquez-Rimachi, Victor Mori, Nicanor Dueñas-Pacheco, Wenzel Ivan Huerta-Rosario, Andrely Farroñay-García, Chandel Molina, Roberto A. and Alva-Díaz, Carlos 2021. Clinical Pathway for the Diagnosis and Management of Patients With Relapsing–Remitting Multiple Sclerosis: A First Proposal for the Peruvian Population. Frontiers in Neurology, Vol. 12, Issue. ,
  • CrossRef
  • Google Scholar
Barboza, Andrés Burgos, Marcos Cáceres, Fernando Carrá, Adriana Correale, Jorge Cristiano, Edgardo Patrucco, Liliana Piedrabuena, Raúl Rojas, Juan I. Sinay, Vladimiro and Ysrraelit, María Célica 2021. Esclerosis múltiple altamente activa y su influencia en la elección del tratamiento. Neurología Argentina, Vol. 13, Issue. 4, p. 241.
  • CrossRef
  • Google Scholar
Sadovnick, Dessa Criscuoli, Maria Yee, Irene Carruthers, Robert Schabas, Alice and Smyth, Penelope 2021. The road to conception for women with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 7, Issue. 3,
  • CrossRef
  • Google Scholar
Thebault, Simon Booth, Ronald A. Rush, Carolina A. MacLean, Heather and Freedman, Mark S. 2021. Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation. Frontiers in Neuroscience, Vol. 15, Issue. ,
  • CrossRef
  • Google Scholar
Muñoz, Ursula Sebal, Cristina Escudero, Esther Urcelay, Elena Arroyo, Rafael García-Martínez, Maria A. Quintana, Francisco J. Alvarez-Lafuente, Roberto and Sádaba, María C. 2021. Serum IgM to Lipids Predicts the Response to Tysabri® and IFN-β in MS. SSRN Electronic Journal ,
  • CrossRef
  • Google Scholar
Bose, Gauruv and Freedman, Mark S. 2021. Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis. Journal of the Neurological Sciences, Vol. 421, Issue. , p. 117324.
  • CrossRef
  • Google Scholar
Morrow, Sarah A. Clift, Fraser Devonshire, Virginia Lapointe, Emmanuelle Schneider, Raphael Stefanelli, Mark and Vosoughi, Reza 2022. Use of natalizumab in persons with multiple sclerosis: 2022 update. Multiple Sclerosis and Related Disorders, Vol. 65, Issue. , p. 103995.
  • CrossRef
  • Google Scholar
Chu, Laura Casserly, Courtney Rosehart, Heather and Morrow, Sarah A. 2022. Is there a multiple sclerosis personality? Personality characteristics in newly diagnosed multiple sclerosis and association with mood and cognition. Journal of the Neurological Sciences, Vol. 434, Issue. , p. 120145.
  • CrossRef
  • Google Scholar
Hoving, M. Jongen, P. J. Evers, S. M. A. A. Edens, M. A. and Zeinstra, E. M. P. E. 2022. MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial. BMC Neurology, Vol. 22, Issue. 1,
  • CrossRef
  • Google Scholar
Inojosa, Hernan Proschmann, Undine Akgün, Katja and Ziemssen, Tjalf 2022. The need for a strategic therapeutic approach: multiple sclerosis in check. Therapeutic Advances in Chronic Disease, Vol. 13, Issue. ,
  • CrossRef
  • Google Scholar
Baharnoori, Moogeh Bhan, Virender Clift, Fraser Thomas, Kimberly Mouallif, Soukaïna Adlard, Nicholas Cooney, Philip Blanchette, François Patel, Barkha P. and Grima, Daniel 2022. Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada. PharmacoEconomics - Open, Vol. 6, Issue. 6, p. 859.
  • CrossRef
  • Google Scholar
Fragoso, Yara Dadalti Branco, Luciana Prats and de Carvalho, Vitor Martinez 2022. Pregnancy and Family Planning Considerations in Multiple Sclerosis. Current Obstetrics and Gynecology Reports, Vol. 11, Issue. 2, p. 90.
  • CrossRef
  • Google Scholar
Guler, Sibel 2022. Factors determining the treatment ineffectiveness in multiple sclerosis. Neurological Research, Vol. 44, Issue. 2, p. 177.
  • CrossRef
  • Google Scholar
Asadollahzade, Elnaz Ghadiri, Fereshteh Ebadi, Zahra and Moghadasi, Abdorreza Naser 2022. Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”. Revista da Associação Médica Brasileira, Vol. 68, Issue. 12, p. 1621.
  • CrossRef
  • Google Scholar
Ford, Corey C Cohen, Jeffrey A Goodman, Andrew D Lindsey, John W Lisak, Robert P Luzzio, Christopher Pruitt, Amy Rose, John Rus, Horea Wolinsky, Jerry S Kadosh, Shaul E Bernstein-Hanlon, Emily Stark, Yafit and Alexander, Jessica K 2022. Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. Multiple Sclerosis Journal, Vol. 28, Issue. 11, p. 1729.
  • CrossRef
  • Google Scholar
Saposnik, Gustavo Andhavarapu, Sanketh Fernández, Óscar Kim, Ho Jin Wiendl, Heinz Foss, Mona Zuo, Fei Havrdová, Eva Kubala Celius, Elisabeth Gulowsen Caceres, Fernando Magyari, Melinda Bermel, Robert Costa, Andreia Terzaghi, Maria Kalincik, Tomas Popescu, Veronica Amato, Maria Pia Montalban, Xavier and Oh, Jiwon 2022. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists. Multiple Sclerosis and Related Disorders, Vol. 57, Issue. , p. 103389.
  • CrossRef
  • Google Scholar
Download full list
Google Scholar Citations

View all Google Scholar citations for this article.

×
Cambridge University Press

Our Site

  • Accessibility
  • Contact & Help
  • Legal Notices

Quick Links

  • Cambridge Core
  • Cambridge Open Engage
  • Cambridge Aspire website

Our Products

  • Journals
  • Books
  • Elements
  • Textbooks
  • Courseware

Join us online

Please choose a valid location.

  • Rights & Permissions
  • Copyright
  • Privacy Notice
  • Terms of Use
  • Cookies Policy
Cambridge University Press 2025

Cancel
Confirm
×

Save article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations
  • Volume 47, Issue 4
  • Mark S. Freedman (a1), Virginia Devonshire (a2), Pierre Duquette (a3), Paul S. Giacomini (a4), Fabrizio Giuliani (a5), Michael C. Levin (a6), Xavier Montalban (a7), Sarah A. Morrow (a8), Jiwon Oh (a7), Dalia Rotstein (a7) and E. Ann Yeh (a9)
  • DOI: https://doi.org/10.1017/cjn.2020.66
Please provide your Kindle email.
Available formats Please select a format to save.
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations
  • Volume 47, Issue 4
  • Mark S. Freedman (a1), Virginia Devonshire (a2), Pierre Duquette (a3), Paul S. Giacomini (a4), Fabrizio Giuliani (a5), Michael C. Levin (a6), Xavier Montalban (a7), Sarah A. Morrow (a8), Jiwon Oh (a7), Dalia Rotstein (a7) and E. Ann Yeh (a9)
  • DOI: https://doi.org/10.1017/cjn.2020.66
Available formats Please select a format to save.
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations
  • Volume 47, Issue 4
  • Mark S. Freedman (a1), Virginia Devonshire (a2), Pierre Duquette (a3), Paul S. Giacomini (a4), Fabrizio Giuliani (a5), Michael C. Levin (a6), Xavier Montalban (a7), Sarah A. Morrow (a8), Jiwon Oh (a7), Dalia Rotstein (a7) and E. Ann Yeh (a9)
  • DOI: https://doi.org/10.1017/cjn.2020.66
Available formats Please select a format to save.
×
×

Reply to: Submit a response

Contents help
Close Contents help

- No HTML tags allowed
- Web page URLs will display as text only
- Lines and paragraphs break automatically
- Attachments, images or tables are not permitted

Please enter your response.

Your details

Email help
Close Email help

Your email address will be used in order to notify you when your comment has been reviewed by the moderator and in case the author(s) of the article or the moderator need to contact you directly.

Please enter a valid email address.
You have entered the maximum number of contributors

Conflicting interests

Do you have any conflicting interests? * Conflicting interests help

Close Conflicting interests help

Please list any fees and grants from, employment by, consultancy for, shared ownership in or any close relationship with, at any time over the preceding 36 months, any organisation whose interests may be affected by the publication of the response. Please also list any non-financial associations or interests (personal, professional, political, institutional, religious or other) that a reasonable reader would want to know about in relation to the submitted work. This pertains to all the authors of the piece, their spouses or partners.